PHCentral RSS - rss FIRE feed Thu, 29 Sep 2016 03:09:15 GMT Australian Triathlete Races Her Way to Silver After 2013 Heart and Double-Lung Transplant September 30, 2016 Pulmonary arterial hypertension in congenital heart disease: Current perspectives and future challenges September 29, 2016 United Therapeutics: Making more lungs viable for transplants September 28, 2016 PAH Researchers Identify Potential New Therapeutic Target September 27, 2016 Several Gene Mutations Seen in PAH Patients with More Severe Disease September 27, 2016 Heart Sounds Checked by Speech Algorithm Diagnose Pulmonary Hypertension Better Than Trained Doctors September 26, 2016 Monitoring Pulmonary Hypertension to Guide Treatment September 26, 2016 Creating 3-D lungs in the lab may lead to better treatment for lung disease September 23, 2016 A case of postpartum pulmonary hypertension complicated with mixed connective tissue disease September 23, 2016 Diabetes and Obesity Treatment Shows Promise in Preventing in Early Study September 22, 2016 Anastrozole in Pulmonary Arterial Hypertension (AIPH): A Randomized, Double-Blind Placebo-Controlled Trial September 22, 2016 ]]> Imatinib could be a new strategy for pulmonary hypertension caused by pulmonary tumor thrombotic microangiopathy in metastatic breast cancer September 21, 2016 ]]> Familial Chronic Thromboembolic Pulmonary Hypertension in a Pair of Japanese Brothers September 21, 2016 Genetically modified probiotic may treat pulmonary hypertension September 20, 2016 New Paradigm for Pulmonary Arterial Hypertension Treatment September 20, 2016 Treprostinil Long-term IV Infusion for PAH: A New Device for Treating Pulmonary Arterial Hypertension September 19, 2016 Efficiency of Mifcare’s Anti-inflammatory Compound for PAH Shown in Second Animal Model September 16, 2016 New technology helps to protect lungs before transplants September 16, 2016 Bronchoscopy Safe for Patients with PH September 15, 2016
Molecular Pathway, Newly Linked to PAH, May Work to Protect Lungs September 14, 2016 Mixed connective tissue disease presenting with isolated pulmonary hypertension, and limited cutaneous sclerosis September 14, 2016 Study Testing if e-Nose Can Detect Pulmonary Arterial Hypertension by Smelling September 13, 2016 Single Lung Transplant in Moderate to Severe Pulmonary Hypertension September 13, 2016 Adempas Aids PAH Patients Not Improving on PDE5i Therapy, Clinical Study Finds September 12, 2016 Severe Pulmonary Arteriopathy Is Associated with Persistent Hypoxemia after Pulmonary Endarterectomy in CTEPH September 12, 2016 Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management Strategies September 9, 2016 Can Pulmonary Hypertension Be Detected in Breath? E-Nose Thinks So September 8, 2016 Be aware of fraudulent stem cell treatments September 8, 2016 Prognostic Factors for Pulmonary Hypertension Include Gender, Age, Chronic Diseases September 7, 2016 Arginase Inhibition Reverses Endothelial Dysfunction, Pulmonary Hypertension, and Vascular Stiffness in Transgenic Sickle Cell Mice September 6, 2016 In Certain CTEPH Patients, Vascular Remodeling May Lead To Hypoxemia September 5, 2016 Biomarkers of tissue remodeling predict survival in patients with pulmonary hypertension September 2, 2016 Endothelin receptor antagonists for persistent pulmonary hypertension in term and late preterm infants September 1, 2016 Karos Reports Positive Safety Data from Phase 1 Trials of PAH Therapy September 1, 2016 Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension August 31, 2016 2 Therapies Intended for Other Diseases May Work to Treat PH August 31, 2016 New Understanding of Pulmonary Hypertension Leads to Promising Drug Targets August 30, 2016 Journal of Clinical Investigation, highlight the use of these drugs to alter vessel stiffness and its downstream control of metabolism, a link previously unknown for people suffering from the progressive disease.]]> Experts seek origin of pulmonary hypertension to design treatment August 30, 2016 Journal of Clinical Investigation, he outlines how two compounds, known as verteporfin and CH-839, show promise in impeding the chain of events that leads from initial stiffness in the arteries to changes in metabolism to heart failure. Doctors have used the compounds to treat cancer and macular degeneration, an eye disease.]]> High-Fat Diet in Diabetic Moms May Add to Risk of Pulmonary Hypertension in Newborn August 30, 2016